Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program
Open Access
- 18 October 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 63 (1), 55-59
- https://doi.org/10.1093/jac/dkn434
Abstract
The aim of this study was to evaluate the occurrence and dissemination of acquired carbapenem-hydrolysing class D β-lactamase (class D carbapenemase)- and metallo-β-lactamase (MBL)-encoding genes among Acinetobacter spp. isolates recovered from medical centres in the Asia-Pacific (APAC) region. During 2006–07, 41 medical centres located in 10 countries in the APAC region forwarded to a central monitoring site 544 Acinetobacter spp. isolates, which were tested for susceptibility by the reference broth microdilution method. Isolates non-susceptible to imipenem or meropenem (MIC ≥8 mg/L) were screened for OXA-23-, OXA-24/40-, OXA-58- and MBL-encoding genes and confirmed by sequencing. Clonality was assessed by ribotyping and PFGE. Polymyxins (99.1% susceptible) and tigecycline (98.9% susceptible) were the most active antimicrobial agents tested. Among the isolates, 230 (42.3%) were non-susceptible to imipenem or meropenem, and class D carbapenemase- or MBL-encoding genes were detected in 162 (70.4%). blaOXA-23 was found in isolates recovered from six countries, while blaOXA-24/40 and blaOXA-58 were less common. Several isolates harboured more than one class D carbapenemase, and MBL-encoding genes were detected in one Acinetobacter johnsonii from the Philippines (blaIMP-4) and one Acinetobacter baumannii from Korea (blaVIM-2). Overall, clonal dissemination was noted within medical centres; however, genetic relatedness was also noted among class D carbapenemase-producing A. baumannii isolates recovered from different countries. This study shows a high distribution of class D carbapenemase-encoding genes, mainly blaOXA-23, in Acinetobacter spp. isolates. In addition, clonal dissemination among medical centres located in different countries in the APAC region, previously documented in many regions of Europe, emphasizes the epidemic potential of these bacteria.Keywords
This publication has 11 references indexed in Scilit:
- Increased Antimicrobial Susceptibility Profiles among Polymyxin‐ResistantAcinetobacter baumanniiClinical IsolatesClinical Infectious Diseases, 2008
- Acinetobacter radioresistensas a Silent Source of Carbapenem Resistance forAcinetobactersppAntimicrobial Agents and Chemotherapy, 2008
- Clonal Spread of Imipenem-Resistant Acinetobacter baumannii among Different Cities of ChinaJournal of Clinical Microbiology, 2007
- Molecular Epidemiology of Clinical Isolates of Carbapenem-Resistant Acinetobacter spp. from Chinese HospitalsAntimicrobial Agents and Chemotherapy, 2007
- Carbapenemases: Molecular Diversity and Clinical ConsequencesFuture Microbiology, 2007
- Global Challenge of Multidrug-ResistantAcinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2007
- Rapid Detection and Identification of Metallo-β-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve AnalysisJournal of Clinical Microbiology, 2007
- Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.International Journal of Antimicrobial Agents, 2006
- Acquired Metallo- -Lactamases: An Increasing Clinical ThreatClinical Infectious Diseases, 2005
- Standardization and Interlaboratory Reproducibility Assessment of Pulsed-Field Gel Electrophoresis-Generated Fingerprints of Acinetobacter baumanniiJournal of Clinical Microbiology, 2005